scholarly journals Smoking and survival after breast cancer diagnosis in Japanese women: A prospective cohort study

2015 ◽  
Vol 106 (8) ◽  
pp. 1066-1074 ◽  
Author(s):  
Yoichiro Kakugawa ◽  
Masaaki Kawai ◽  
Yoshikazu Nishino ◽  
Kayoko Fukamachi ◽  
Takanori Ishida ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Prospective Cohort Study ◽  
Cancer Diagnosis ◽  
Prospective Cohort ◽  
Breast Cancer Diagnosis ◽  
Japanese Women

Changes in employment status up to 5 years after breast cancer diagnosis: A prospective cohort study

The Breast ◽  
2019 ◽  
Vol 48 ◽  
pp. 38-44
Author(s):  
Isabel Monteiro ◽  
Samantha Morais ◽  
Ana Rute Costa ◽  
Luisa Lopes-Conceição ◽  
Natália Araújo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Prospective Cohort Study ◽  
Cancer Diagnosis ◽  
Prospective Cohort ◽  
Employment Status ◽  
Breast Cancer Diagnosis

scholarly journals Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study

The Breast ◽  
2017 ◽  
Vol 32 ◽  
pp. 173-178 ◽  
Author(s):  
Mariana Ramalho ◽  
Filipa Fontes ◽  
Luís Ruano ◽  
Susana Pereira ◽  
Nuno Lunet
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Cognitive Impairment ◽  
Prospective Cohort Study ◽  
Cancer Diagnosis ◽  
Prospective Cohort ◽  
Breast Cancer Diagnosis ◽  
First Year

scholarly journals Alcohol consumption and survival after breast cancer diagnosis in Japanese women: A prospective patient cohort study

PLoS ONE ◽  
2019 ◽  
Vol 14 (11) ◽  
pp. e0224797
Author(s):  
Yuko Minami ◽  
Seiki Kanemura ◽  
Masaaki Kawai ◽  
Yoshikazu Nishino ◽  
Hiroshi Tada ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Alcohol Consumption ◽  
Cancer Diagnosis ◽  
Breast Cancer Diagnosis ◽  
Japanese Women ◽  
Patient Cohort

Cynical distrust increases breast cancer risk: Evidence from a prospective cohort study

2002 ◽  
Author(s):  
A. R. Aro ◽  
H. J. de Koning ◽  
K. Vehkalahti ◽  
P. Absetz ◽  
M. Schreck ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Prospective Cohort Study ◽  
Prospective Cohort

scholarly journals The INTREST registry: protocol of a multicenter prospective cohort study of predictors of women’s response to integrative breast cancer treatment

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Heidemarie Haller ◽  
Petra Voiß ◽  
Holger Cramer ◽  
Anna Paul ◽  
Mattea Reinisch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Cohort Study ◽  
Cancer Treatment ◽  
Prospective Cohort Study ◽  
Cancer Care ◽  
Prospective Cohort ◽  
Breast Cancer Treatment ◽  
Cancer Data ◽  
Patient Reported

Abstract Background Cancer registries usually assess data of conventional treatments and/or patient survival. Beyond that, little is known about the influence of other predictors of treatment response related to the use of complementary therapies (CM) and lifestyle factors affecting patients’ quality and quantity of life. Methods INTREST is a prospective cohort study collecting register data at multiple German certified cancer centers, which provide individualized, integrative, in- and outpatient breast cancer care. Patient-reported outcomes and clinical cancer data of anticipated N = 715 women with pTNM stage I-III breast cancer are collected using standardized case report forms at the time of diagnosis, after completing neo−/adjuvant chemotherapy, after completing adjuvant therapy (with the exception of endocrine therapy) as well as 1, 2, 5, and 10 years after baseline. Endpoints for multivariable prediction models are quality of life, fatigue, treatment adherence, and progression-based outcomes/survival. Predictors include the study center, sociodemographic characteristics, histologic cancer and comorbidity data, performance status, stress perception, depression, anxiety, sleep quality, spirituality, social support, physical activity, diet behavior, type of conventional treatments, use of and belief in CM treatments, and participation in a clinical trial. Safety is recorded following the Common Terminology Criteria for Adverse Events. Discussion This trial is currently recruiting participants. Future analyses will allow to identify predictors of short- and long-term response to integrative breast cancer treatment in women, which, in turn, may improve cancer care as well as quality and quantity of life with cancer. Trial registration German Clinical Trial Register DRKS00014852. Retrospectively registered at July 4th, 2018.

Sign in / Sign up

Export Citation Format

Share Document